Registered number
04334810
The Bristol & Avon Dermatology Research Trust Limited
Financial Statements
31 March 2025
The Bristol & Avon Dermatology Research Trust Limited
Report and accounts
Contents
Page
Company information 1
Directors' report 2
Accountants' report 3
Profit and loss account 4
Balance sheet 5
Statement of changes in equity 6
Notes to the accounts 7
The Bristol & Avon Dermatology Research Trust Limited
Company Information
Directors
Janet Angus (appointed 31 December 2024)
Secretary
Janet Angus
Accountants
TYRRELL PROCTER
Chartered Accountants
Beaufort House
113 Parson Street
Bristol
BS3 5QH
Registered office
Bristol Royal Infirmary
Marlborough Street,
Bristol
England
BS2 8HW
Registered number
04334810
The Bristol & Avon Dermatology Research Trust Limited
Registered number: 04334810
Directors' Report
The directors present their report and accounts for the year ended 31 March 2025.
Principal activities
The company's principal activity during the year continued to be that of a research trust.
Directors
The following persons served as directors during the year:
Janet Angus (appointed 31 December 2024)
Small company provisions
This report has been prepared in accordance with the provisions in Part 15 of the Companies Act 2006 applicable to companies subject to the small companies regime.
This report was approved by the board on 16 December 2025 and signed on its behalf.
Janet Angus
Director
The Bristol & Avon Dermatology Research Trust Limited
Chartered Accountants' report to the board of directors on the preparation of the unaudited statutory accounts of The Bristol & Avon Dermatology Research Trust Limited for the year ended 31 March 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of The Bristol & Avon Dermatology Research Trust Limited for the year ended 31 March 2025 which comprise of the Profit and Loss Account, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales, we are subject to its ethical and other professional requirements which are detailed at
www.icaew.com/en/members/regulations-standards-and-guidance
This report is made solely to the Board of Directors of The Bristol & Avon Dermatology Research Trust Limited, as a body, in accordance with the terms of our engagement letter dated 17 October 2025. Our work has been undertaken solely to prepare for your approval the accounts of The Bristol & Avon Dermatology Research Trust Limited and state those matters that we have agreed to state to the Board of Directors of The Bristol & Avon Dermatology Research Trust Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than The Bristol & Avon Dermatology Research Trust Limited and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that The Bristol & Avon Dermatology Research Trust Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of The Bristol & Avon Dermatology Research Trust Limited. You consider that The Bristol & Avon Dermatology Research Trust Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of The Bristol & Avon Dermatology Research Trust Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
TYRRELL PROCTER
Chartered Accountants
Beaufort House
113 Parson Street
Bristol
BS3 5QH
16 December 2025
The Bristol & Avon Dermatology Research Trust Limited
Profit and Loss Account
for the year ended 31 March 2025
2025 2024
£ £
Administrative expenses (9,477) (8,174)
Other operating income - 2,122
Operating loss (9,477) (6,052)
Interest receivable 1,197 1,017
Loss before taxation (8,280) (5,035)
Tax on loss - -
Loss for the financial year (8,280) (5,035)
The Bristol & Avon Dermatology Research Trust Limited
Registered number: 04334810
Balance Sheet
as at 31 March 2025
Notes 2025 2024
£ £
Current assets
Cash at bank and in hand 92,726 101,050
Creditors: amounts falling due within one year 3 44 -
Net current assets 92,770 101,050
Total assets less current liabilities 92,770 101,050
Creditors: amounts falling due after more than one year 4 (200) (200)
Net assets 92,570 100,850
Capital and reserves
Profit and loss account 92,570 100,850
Shareholders' funds 92,570 100,850
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Janet Angus
Director
Approved by the board on 16 December 2025
The Bristol & Avon Dermatology Research Trust Limited
Statement of Changes in Equity
for the year ended 31 March 2025
Share Share Re- Profit Total
capital premium valuation and loss
reserve account
£ £ £ £ £
At 1 April 2023 - - - 105,885 105,885
Loss for the financial year (5,035) (5,035)
At 31 March 2024 - - - 100,850 100,850
At 1 April 2024 - - - 100,850 100,850
Loss for the financial year (8,280) (8,280)
At 31 March 2025 - - - 92,570 92,570
The Bristol & Avon Dermatology Research Trust Limited
Notes to the Accounts
for the year ended 31 March 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company - -
3 Creditors: amounts falling due within one year 2025 2024
£ £
Other creditors (44) -
4 Creditors: amounts falling due after one year 2025 2024
£ £
Other creditors 200 200
5 Other information
The Bristol & Avon Dermatology Research Trust Limited is a private company limited by shares and incorporated in England. Its registered office is:
Bristol Royal Infirmary
Marlborough Street,
Bristol
England
BS2 8HW
The Bristol & Avon Dermatology Research Trust Limited 04334810 false 2024-04-01 2025-03-31 2025-03-31 VT Final Accounts November 2025 04334810 2023-04-01 2024-03-31 04334810 core:WithinOneYear 2024-03-31 04334810 core:AfterOneYear 2024-03-31 04334810 core:RetainedEarningsAccumulatedLosses 2024-03-31 04334810 2023-03-31 04334810 core:ShareCapital 2023-03-31 04334810 core:SharePremium 2023-03-31 04334810 core:OtherReservesSubtotal 2023-03-31 04334810 core:RetainedEarningsAccumulatedLosses 2023-03-31 04334810 2024-04-01 2025-03-31 04334810 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04334810 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 04334810 bus:Director2 2024-04-01 2025-03-31 04334810 bus:CompanySecretary1 2024-04-01 2025-03-31 04334810 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 04334810 1 2024-04-01 2025-03-31 04334810 2 2024-04-01 2025-03-31 04334810 countries:England 2024-04-01 2025-03-31 04334810 bus:FRS102 2024-04-01 2025-03-31 04334810 bus:FullAccounts 2024-04-01 2025-03-31 04334810 2025-03-31 04334810 core:WithinOneYear 2025-03-31 04334810 core:AfterOneYear 2025-03-31 04334810 core:RetainedEarningsAccumulatedLosses 2025-03-31 04334810 core:ShareCapital 2025-03-31 04334810 core:SharePremium 2025-03-31 04334810 core:OtherReservesSubtotal 2025-03-31 04334810 2024-03-31 04334810 core:ShareCapital 2024-03-31 04334810 core:SharePremium 2024-03-31 04334810 core:OtherReservesSubtotal 2024-03-31 iso4217:GBP xbrli:pure